BILLS-117hr2623ih.pdf
House Resolutions
0 pages
Page
of 0
Loading OCR text...
No OCR text available for this page.
Failed to load OCR text.
DATE (6)
1986
APRIL 16, 2021
years
1ST SESSION H. R. 2623
later than 1 year
later than 3 months
FAC (4)
PO 00000
Frm 00001
PO 00000
Frm 00004
PO 00000
Frm 00003
Fmt
PO 00000
Frm 00002
GPE (2)
2623 IH
the United States of America
ORG (13)
DSK79L0C42PROD
Congress
the Committee on Energy and Commerce
THE HOUSE OF REPRESENTATIVES
Internal
House of Representa-
the Federal Food, Drug
Control and Prevention
Senate
the Committee on Ways and Means
SEC
CDC FEASIBILITY STUDY
PERSON (2)
GOTTHEIMER
UPTON
Topic Classifications
congressional legislation
97.9%
public health
75.9%
government oversight
53.4%
Extracted Keywords
rare diseases
diseases conditions
rare
diseases
tax credit
disease condition
surveillance
director shall
study
study required
conditions
drug
director
feasibility
credit
Forensic Analysis
PDF Metadata
- Creator
- U.S. Gov. Printing Office -- G.S.D.D.
- ModDate
- D:20221230145959Z
- Producer
- Acrobat Distiller 21.0 (Windows); modified using iText® Core 7.2.3 (production version) ©2000-2022 iText Group NV, Government Publishing Office
- CreationDate
- D:20210609001840-04'00'
Sentiment
Polarity
Positive
0.128
Subjectivity
54%
Subjective